These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34579211)

  • 1. Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination.
    Lim XR; Leung BP; Ng CYL; Tan JWL; Chan GYL; Loh CM; Tan GLX; Goh VHH; Wong LT; Chua CR; Tan SC; Lee SSM; Howe HS; Thong BYH; Leong KP
    Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylatoxin Complement 5a in Pfizer BNT162b2-Induced Immediate-Type Vaccine Hypersensitivity Reactions.
    Lim XR; Chan GYL; Tan JWL; Ng CYL; Chua CG; Tan GB; Chan SSW; Ong KH; Tan YZ; Tan SHZ; Teo CML; Lee SSM; Thong BYH; Leung BPL
    Vaccines (Basel); 2023 May; 11(6):. PubMed ID: 37376409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Patients with Vaccine Allergies Prior to mRNA-Based COVID-19 Vaccination.
    Lim XR; Tan JWL; Chan GYL; Hou J; Xie L; Goh VHL; Boon J; Lee SSM; Teo CM; Tan SC; Leong KP; Thong BYH; Leung BPL
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination.
    Zhou ZH; Cortese MM; Fang JL; Wood R; Hummell DS; Risma KA; Norton AE; KuKuruga M; Kirshner S; Rabin RL; Agarabi C; Staat MA; Halasa N; Ware RE; Stahl A; McMahon M; Browning P; Maniatis P; Bolcen S; Edwards KM; Su JR; Dharmarajan S; Forshee R; Broder KR; Anderson S; Kozlowski S
    Vaccine; 2023 Jun; 41(28):4183-4189. PubMed ID: 37244808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comirnaty-induced cardiopulmonary distress and other symptoms of complement-mediated pseudo-anaphylaxis in a hyperimmune pig model: Causal role of anti-PEG antibodies.
    Barta BA; Radovits T; Dobos AB; Tibor Kozma G; Mészáros T; Berényi P; Facskó R; Fülöp T; Merkely B; Szebeni J
    Vaccine X; 2024 Aug; 19():100497. PubMed ID: 38933697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspected Anaphylactic Reaction Following Second Dose of the Pfizer-BioNTech (BNT162b2) Coronavirus Vaccine in a Geriatric Female.
    Hong A; Sardinas G
    HCA Healthc J Med; 2022; 3(6):349-354. PubMed ID: 37427315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylaxis is a rare reaction in COVID-19 vaccination.
    Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
    J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged Anaphylaxis to Pfizer Coronavirus Disease 2019 Vaccine: A Case Report and Mechanism of Action.
    Frank A; Radparvar S; Manasia A; Bassily-Marcus A; Kohli-Seth R
    Crit Care Explor; 2021 Apr; 3(4):e0397. PubMed ID: 33834172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
    Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G
    Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor.
    Dézsi L; Mészáros T; Kozma G; H-Velkei M; Oláh CZ; Szabó M; Patkó Z; Fülöp T; Hennies M; Szebeni M; Barta BA; Merkely B; Radovits T; Szebeni J
    Geroscience; 2022 Apr; 44(2):597-618. PubMed ID: 35146583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers].
    Rojkovich B; Németh D; Török E; Szabó B; Pintér Á; Juhász I; Weidl M; Lányi É; Pável-Szecskó J; Lázár I; Perduk A; Reiter J; Nagy G; Nagy E; Géher P
    Orv Hetil; 2021 Sep; 162(39):1551-1557. PubMed ID: 34570721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of the Second Dose of mRNA COVID-19 Vaccine to a Woman With Immediate Reaction to the First Dose.
    Apostolidou E; Dimitriou K; Papadopoulou A; Mikos N; Kompoti E
    Cureus; 2023 Mar; 15(3):e36064. PubMed ID: 37056532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA).
    Klimek L; Novak N; Hamelmann E; Werfel T; Wagenmann M; Taube C; Bauer A; Merk H; Rabe U; Jung K; Schlenter W; Ring J; Chaker A; Wehrmann W; Becker S; Mülleneisen N; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Jakob T; Ankermann T; Schmidt SM; Gerstlauer M; Vogelberg C; Zuberbier T; Hartmann K; Worm M
    Allergo J Int; 2021; 30(2):51-55. PubMed ID: 33643776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population.
    Guzmán-Martínez O; Guardado K; de Guevara EL; Navarro S; Hernández C; Zenteno-Cuevas R; Montero H
    Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations.
    Kounis NG; Koniari I; de Gregorio C; Velissaris D; Petalas K; Brinia A; Assimakopoulos SF; Gogos C; Kouni SN; Kounis GN; Calogiuri G; Hung MY
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33807579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Severe Anaphylactic Reaction Associated with IgM-Class Anti-Human IgG Antibodies in a Hyper-IgM Syndrome Type 2 Patient.
    Tsujita Y; Imai K; Honma K; Kamae C; Horiuchi T; Nonoyama S
    J Clin Immunol; 2018 Jan; 38(1):144-148. PubMed ID: 29255996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.